Become an o2h Discovery ‘Platinum Partner’ Platinum Partners are investors in biotech and are automatically eligible to provide new portfolio companies with an ‘o2h Kickstarter Award’ alongside their first investment into a small molecule therapeutic start-up
o2h kickstarter awards: key highlights
8+
Editions completed
globally
40+
Awards provided
so far
$7.2M+
Invested in resources
about o2h discovery platinum partners
Building on the success of our o2h Kickstarter Awards, we’ve decided to invite investors in startups, whether they be Venture Capital, Venture Builders or Technology Transfer offices, to provide their new investments with a Kickstarter Award on ‘Auto Pilot’. This approach allows us to distribute more awards to companies helping them access this crucial support through their Pre Seed and Seed rounds.
We all know how tough it is to advance biotechs through the early stages, and our Platinum Partners will be working hard to support these companies with funds and more. This award aims to provide a chemistry boost to help recipient companies achieve their project milestones.
winners of o2h kickstarter competition
Alevin Therapeutics
Developing a platform of novel small molecule RGD integrin inhibitors with superior drug-like qualities
Kuano
De-risking and accelerating drug discovery by combining quantum and AI
Sevenless Therapeutics
Developing technique to uncover a novel chronic pain signaling target
Five Alarm Bio
Seeking to develop drugs to slow down the ageing process
Origami Therapeutics
Developing next-generation disease-modifying protein degraders and correctors
Psylo
Next-generation neuroscience for transformative treatments
Gertrude Biomedical
Creating innovative and transformational oncology therapeutics, accelerating progress towards a brighter future for sufferers of untreatable cancers.
Protai
AI-powered drug discovery startup that is revolutionizing the way new drugs can be discovered
Azadyne
Azadyne are a preclinical biotech company with a new approach to treating autoimmune disease. We have identified a new target within the body and a previously undrugged pathway.
ProteKt Therapeutics
ProteKt Therapeutics has discovered and developed a series of novel and selective molecules by applying unique computational methods and validating the inhibitors in clinically relevant assays
Monash University
Monash is a research-intensive university, known for some significant and lasting discoveries that have delivered impact beyond the academic community.
about the o2h kickstarter award
Launched in August 2022, the o2h Kickstarter competition aims to empower early-stage biotech companies striving to amplify their chemistry initiatives and secure their next funding milestone. We understand that drug discovery research is a complex phenomenon which often involves synthesising and screening vast numbers of molecules to uncover promising ‘hits.’ We’ve launched 5+ editions across diverse regions, including the UK, Australia, Israel, Italy, and the USA, garnering an overwhelming response with over 20 awards provided.
kickstarter benefits
team
A dedicated team of six FTE synthetic chemists of which two are senior and four are junior chemists
Cost & Duration
Six synthetic chemists at a fraction of the usual price for up to six months
Additional Support
Receive 100 complimentary ADME points and save 20% on Biology FTE
Inventory
Access to a large inventory of chemicals and reagents for synthesis
eligibility
The award is for pre-seed and seed stage small molecule focused biotech companies which have secured initial funding from o2h approved Investors.
Register nowwinners feedback
More than 80 companies applied from across the globe, and here are the few companies who made it to the winners list.
Dr Neil Benson
CEO
Winning the o2h Kickstarter competition will significantly increase our chemistry resource and in turn accelerate delivery of our goals.
Read more onLinkedIn
Jason Rutt
CEO
We are absolutely delighted to win an inaugural kickstarter award. It's fantastic that one of Britains top CROs is prepared to back companies like ours.
Read more onLinkedIn
Chris Moody
Co-founder
the o2h kickstarter competition promises to be an excellent scheme allowing early-stage companies like ours to get access to synthetic chemistry.
Read more onLinkedIn
Vid Stojevic
CEO & Co-founder
The kickstarter provides vital access to chemists with the skills and knowledge to deliver on the promise of our technology.
Read more onLinkedIn
Dr Janette A Thomas
CEO
I am thrilled that Five Alarm Bio has been awarded the Kickstarter program. We will benefit from the extensive knowledge and enthusiasm of the o2h leadership and laboratory scientists.
Read more onLinkedIn
Beth J Hoffman
President & CEO
The Kickstarter will enable us to thoroughly explore our nascent SAR and advance our lead program more rapidly.
Read more onLinkedInplatinum partner approval team
Sunil Shah
CEO, o2h ventures and Co-founder, o2h discovery
CEO, o2h ventures and Co-founder, o2h discovery
Gayathri Sadasivam
VP, Biology, o2h discovery
VP, Biology, o2h discovery
Andy Morley
Chief Scientific Officer, o2h discovery
Chief Scientific Officer, o2h discovery
Hemal Soni
Head of Chemistry, o2h discovery
Head of Chemistry, o2h discovery
o2h platinum partners
